Skip to main content

Table 2 Characteristics of 32 Asymptomatic Carriers of Clostridium difficile and 218 Non-carriers

From: Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?

Characteristic

All participants (N = 250)

Asymptomatic carriers (N = 32)

Non-carriers (N = 218)

P value

Mean (SD) age (years)

66.9 (11.9)

64.3 (12.1)

67.2 (11.8)

0.19

Median (IQR) days from admission to culture

9 (4, 15)

11.5 (6, 20.5)

8 (4, 14)

0.07

Days from admission to culture

 0–7

110

13 (41)

97 (44)

0.34

 8–14

75

7 (22)

68 (31)

 

 15–21

27

4 (12)

23 (11)

 

 ≥22

38

8 (25)

30 (14)

 

CDI in the previous 90 days

13

6 (19)

7 (3)

<0.001

Antibiotics in the past 90 days

155

27 (84)

128 (59)

0.005

Antibiotics in the past 30 days

144

24 (75)

120 (55)

0.03

Current antibiotic treatment

98

12 (38)

86 (39)

0.83

Comorbidities

 Heart disease

95

9 (28)

86 (39)

0.22

 Cancer

85

12 (37)

73 (33)

0.65

 Diabetes

103

11 (34)

92 (42)

0.40

 End stage renal disease

23

3 (9)

20 (9)

0.97

 Major surgery

70

8 (25)

62 (28)

0.69

 Spinal cord injury

21

4 (13)

17 (8)

0.32

  1. Data are no. (%) of patients, unless otherwise specified. SD standard deviation, IQR interquartile range